Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: A case report with a long term follow-up

Annals of Hepatology

Volumn 10, Issue 1, 2011, Pages 99-102

  Salech, Felipe ^a   Valderrama, Sebastián ^b   Nervi, Bruno ^b   Rodriguez, Juan Carlos ^b   Oksenberg, Danny ^a   Koch, Alvaro ^c   Smok, Gladys ^a   Duarte, Ignacio ^b   Pérez Ayuso, Rosa María ^b   Jarufe, Nicolás ^b   Martínez, Jorge ^b   Soza, Alejandro ^b   Arrese, Marco ^b   Riquelme, Arnoldo ^a,b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Anti angiogenic therapy; Endothelial tumors; Hepatic tumors

Indexed keywords

ALKALINE PHOSPHATASE; CD31 ANTIGEN; CD34 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; THALIDOMIDE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; ASPIRATION BIOPSY; ASTHENIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEMANGIOENDOTHELIOMA; HEPATIC EPITHELIOID HEMANGIOENDOTHELIOM; HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; LIVER BIOPSY; LUNG METASTASIS; METASTASIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; SPLENOMEGALY; TUMOR VOLUME; VIDEO ASSISTED THORACOSCOPIC SURGERY; WEIGHT REDUCTION;

EID: 79955981822     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31596-0     Document Type: Article

References (18)

1. Lauffer JM, Zimmermann A, Krahenbuhl L, Triller J, Baer HU. Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer 1996; 78: 2318-2327.
2. Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984;15: 839-852.
3. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, Schirmacher P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006; 107: 2108-2121.
4. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999; 85: 562-582.
5. Rodriguez JA, Becker NS, O'Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 2008; 12: 110-116.
6. Grossman EJ, Millis JM. Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl 2010; 16: 930-942.
7. Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, Boleslawski E, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg 2007; 246: 949-957; discussion 957.
8. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RC. Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg 2008; 74: 64-68.
9. Lin J, Ji Y. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. Hepatobiliary Pancreat Dis Int 2010; 9: 154-158.
10. Matsushita M, Shimizu S, Nagasawa M, Katayama M, Masui T, Souda K, Kobayashi Y, et al. Epithelioid hemangioendothelioma of the liver: imaging diagnosis of a rare hepatic tumor. Dig Surg 2005; 22: 416-418.
11. Kitapci MT, Akkas BE, Gullu I, Sokmensuer C. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature. Ann Nucl Med 2010; 24: 549-553.
12. Emamaullee JA, Edgar R, Toso C, Thiesen A, Bain V, Bigam D, Kneteman N, et al. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl 2010; 16: 191-197.
13. Otrock ZK, Al-Kutoubi A, Kattar MM, Zaatari G, Soweid A. Spontaneous complete regression of hepatic epithelioid haemangioendothelioma. Lancet Oncol 2006; 7: 439-441.
14. Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther 2003; 25: 342-395.
15. Mascarenhas RC, Sanghvi AN, Friedlander L, Geyer SJ, Beasley HS, Van Thiel DH. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 2004; 67: 471-475.
16. Kassam A, Mandel K. Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl. J Pediatr Hematol Oncol 2008; 30: 550-552.
17. Belmont L, Zemoura L, Couderc LJ. Pulmonary epithelioid haemangioendothelioma and bevacizumab. J Thorac Oncol 2008; 3: 557-558.
18. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 2010; 22: 351-355.